Salih Karatlı

7PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersMolecular targetsMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Quality of Life and Psychological Factors in Patients with Metastatic Prostate Cancer Receiving Androgen Receptor-Targeted Therapies: A Prospective Cross-Sectional Real-World Study.

|May 04, 2026
Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study.

|May 04, 2026
Prognostic Role of Nutritional and Inflammatory Indices in Predicting Adverse Clinical Outcomes in Unplanned Hospitalized Oncology Patients.

|Apr 14, 2026
Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis.

Selahattin Çelik, Engin Eren Kavak, Esra Zeynelgil

|Jan 27, 2026
Low HALP Score Predicts Prolonged Hospitalization in Solid Tumor Patients with Febrile Neutropenia.

Salih Karatlı, Doğan Yazılıtaş

|Nov 28, 2025
Correction: CALLY index as an independent predictor of pathological complete response in HER2‑positive breast cancer receiving neoadjuvant therapy.

Salih Karatlı, Özgen Ahmet Yıldırım

Pageof 2

Frequent Collaborators

3 joint publications

Özgen Ahmet Yıldırım

3 joint publications

Selahattin Çelik

2 joint publications

Mehmetcan Atak

1 joint publications

Doğan Yazılıtaş